Browsing: Uncategorized

Multiomics, rooted in research, is increasingly closing in on clinical practice, to the point that institutions should be at least…

Company Q1 Investor Calls: Most IVD companies have downplayed tariff impact. Small % of revenues affected. Most emphasizing the industry’s…

How are IVD stocks doing in the general market fall? About that huge flu season. A mid-size player reports, which…

IVD markets grow faster where there is a need for cost-reduction and outcome improvement. This is true with sepsis. This…

MA-based Nova Biomedical and its blood analyzers and handheld meter-and-strip systems will be purchased by osmometer and bioprocessing expert Advanced…

https://www.youtube.com/watch?v=kBV6sE24omM&t=1058sMost IVDs are commodity tests, and growth of value and scope is the way to counter that, said Greg Powell,…

Increasingly, using other companies to perform manufacturing work has become common in in vitro diagnostics. That would not have been…

Sign up now, there’s only 100 slots for this webinar. JOIN HERE FOR ZOOM WEBINAR: https://us06web.zoom.us/webinar/register/WN_RpmYgJtFS_qbg5HZNEZfEg

It would be a stretch to say the J.P. Morgan Healthcare Conference is an in vitro diagnostics meeting. Healthcare IT…

Lab-developed tests, lab consolidation and infectious disease threats dominated the news relative to in vitro diagnostic (IVD) companies in 2024,…